Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
| 660.63 Delayed Data As of May 20 |  +3.48 / +0.53%Today’s Change | 492.13 Today|||52-Week Range 747.42 | +4.61% Year-to-Date |
Latest REGN News | Press Releases
Today’s Trading
| Previous close | 657.15 |
| Today’s open | 661.65 |
| Day’s range | 647.50 - 664.90 |
| Volume | 23,208 |
| Average volume (3 months) | 706,443 |
| Market cap | $70.9B |
Data as of 4:04pm ET, 05/20/2022
Growth & Valuation
| Earnings growth (last year) | +133.99% |
| Earnings growth (this year) | -40.99% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +89.14% |
| P/E ratio | 9.4 |
| Price/Sales | 4.41 |
| Price/Book | 3.74 |
Competitors
Data as of 4:04pm ET, 05/20/2022
Financials
| Next reporting date | August 4, 2022 |
| EPS forecast (this quarter) | $10.18 |
| Annual revenue (last year) | $16.1B |
| Annual profit (last year) | $8.1B |
| Net profit margin | 50.25% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Tarrytown, New York |
Forecasts
